Helping to Close the Care Gap this World Cancer Day
World Cancer Day is an annual global initiative that takes place on the 4th of February. It is led by the Union for International Cancer Control (UICC), an organisation dedicated to uniting the global cancer community. Their aim is to reduce cancer burden, driving to achieve greater equity, and to ensure that cancer control remains a priority on the world health and development agenda.
The World Cancer Day global initiative first launched in 2000 at the World Summit Against Cancer for the New Millenium in Paris.
Between 2022-2024 the theme for World Cancer Day is “Close the Care Gap”. This year, in 2024, collaboration and the power of people working together is the key to making a difference and helping reduce the impact of cancer globally – ideally with modes of diagnosis, treatment, and care available to all regardless of where someone lives or who they are.
At GenesisCare, our aim is to offer a personalised cancer care experience, striving to achieve the best possible clinical outcomes, close to home. In Australia we treat approximately 30,000 patients per year across most adult tumour streams including breast, prostate, lung, skin, and pancreatic cancers. Treatment is offered at more than 40 metro and regional cancer care centres in Queensland, New South Wales, Victoria, South Australia, and Western Australia.
One area of the GenesisCare business that is incredibly important to us is our national Research team. We challenge ourselves every day to help find new and better ways to provide evidence-based care, with access offered to our network of clinical trials, for appropriate patients. Our Research team supports a wide range of industry, collaborative, and investigator-initiated clinical trials from phase 0 through to phase IV in medical oncology, radiation oncology, haematology, theranostics, and precision medicine.
In 2024, we are able to offer access to clinical trials for appropriate patients in Australia at more than 40 sites. In 2023, GenesisCare patients participated in over 130 active research projects*, with more than 2,500 of our patients in trials run by various sponsors. Our Australian research team is made up of more than 55 staff and 75 Principal Investigators across our experienced and respected clinician bench. Our participation in clinical trials provides us with the opportunity to collect clinical evidence to help inform treatment protocols, advance product development, and innovate new therapies.
We are proud to support the World Cancer Day global initiative. For us, partnering and working together to help reduce the impact of cancer in metro and regional areas of Australia is something we passionately strive to achieve every day.
*An active study can be any study that is currently active, recruiting, or in follow-up.
